NEU 2.90% $19.86 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-23

  1. 915 Posts.
    lightbulb Created with Sketch. 254
    that was my initial thought ajostu - these look far stronger.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.